Givaudan | GIVN - Betriebsergebnis

Aktienkurs
2,789.50
Täglich Wechseln
54.50 1.99%
Monatlich
3.20%
Jährlich
-30.00%
Q2 Prognose
2,730.14




Betriebsergebnis Veränderung Datum
Air Liquide EUR 2.84B 6.65B 2025-12
Akzo Nobel EUR 254M 37M 2026-03
Anheuser-Busch USD 4.07B 24M 2026-03
Arkema EUR 80.9M 55.9M 2026-03
Associated British Foods GBP 620M 205M 2026-06
BASF EUR 1.4B 1.58B 2026-03
Bayer EUR 1.11B 1.65B 2025-12
Beiersdorf EUR 504M 312M 2025-12
British American Tobacco GBP 5B 86M 2025-12
Covestro EUR -324M 5.72B 2025-12
Croda International GBP 113M 53.55M 2024-12
Danone EUR 1.86B 48M 2025-12
Diageo GBP 3.26B 1.92B 2025-12
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 268M 395M 2026-03
Givaudan CHF 610M 149M 2025-12
Heineken EUR 1.97B 40M 2025-12
Henkel EUR 1.42B 187M 2025-12
International Flavors Fragrances USD 272M 159M 2026-03
Johnson Matthey GBP 142M 89M 2025-12
Kerry EUR 463.5M 94.2M 2024-12
Lonza CHF 673M 243M 2025-06
L'Oréal EUR 3.92B 824.8M 2025-12
Merck EUR 474M 738M 2025-12
Nestle CHF 6.84B 293M 2025-12
Pernod Ricard EUR 1.61B 644M 2025-12
Reckitt Benckiser GBP 747M 92M 2024-12
SGS CHF 253M 45.5M 2024-12
Sika AG CHF 724.9M 73.2M 2025-12
Solvay EUR 60M 78M 2025-12
Tate & Lyle GBP 129M 0 2025-12
Umicore EUR 713.86M 409.56M 2025-12
Victrex GBP 22.9M 1.1M 2025-12